Diabetes mellitus and the risk of Alzheimer's disease: a nationwide population-based study
- PMID:24489845
- PMCID: PMC3906115
- DOI: 10.1371/journal.pone.0087095
Diabetes mellitus and the risk of Alzheimer's disease: a nationwide population-based study
Abstract
Objectives: Possible association between diabetes mellitus (DM) and Alzheimer's disease (AD) has been controversial. This study used a nationwide population-based dataset to investigate the relationship between DM and subsequent AD incidence.
Methods: Data were collected from Taiwan's National Health Insurance Research Database, which released a cohort dataset of 1,000,000 randomly sampled people and confirmed it to be representative of the Taiwanese population. We identified 71,433 patients newly diagnosed with diabetes (age 58.74 ± 14.02 years) since January 1997. Using propensity score, we matched them with 71,311 non-diabetic subjects by time of enrollment, age, gender, hypertension, hyperlipidemia, and previous stroke history. All the patients were followed up to December 31, 2007. The endpoint of the study was occurrence of AD.
Results: Over a maximum 11 years of follow-up, diabetic patients experienced a higher incidence of AD than non-diabetic subjects (0.48% vs. 0.37%, p<0.001). After Cox proportional hazard regression model analysis, DM (hazard ratio [HR], 1.76; 95% confidence interval [CI], 1.50-2.07, p<0.001), age (HR, 1.11; 95% CI, 1.10-1.12, p<0.001), female gender (HR, 1.24; 95% CI, 1.06-1.46, p=0.008), hypertension (HR, 1.30; 95% CI, 1.07-1.59, p=0.01), previous stroke history (HR, 1.79; 95% CI, 1.28-2.50, p<0.001), and urbanization status (metropolis, HR, 1.32; 95% CI, 1.07-1.63, p=0.009) were independently associated with the increased risk of AD. Neither monotherapy nor combination therapy with oral antidiabetic medications were associated with the risk of AD after adjusting for underlying risk factors and the duration of DM since diagnosis. However, combination therapy with insulin was found to be associated with greater risk of AD (HR, 2.17; 95% CI, 1.04-4.52, p=0.039).
Conclusion: Newly diagnosed DM was associated with increased risk of AD. Use of hypoglycemic agents did not ameliorate the risk.
Conflict of interest statement
Figures


Similar articles
- Association between normal tension glaucoma and the risk of Alzheimer's disease: a nationwide population-based cohort study in Taiwan.Chen YY, Lai YJ, Yen YF, Shen YC, Wang CY, Liang CY, Lin KH, Fan LW.Chen YY, et al.BMJ Open. 2018 Nov 5;8(11):e022987. doi: 10.1136/bmjopen-2018-022987.BMJ Open. 2018.PMID:30397009Free PMC article.
- Incidence and risk of seizures in Alzheimer's disease: A nationwide population-based cohort study.Cheng CH, Liu CJ, Ou SM, Yeh CM, Chen TJ, Lin YY, Wang SJ.Cheng CH, et al.Epilepsy Res. 2015 Sep;115:63-6. doi: 10.1016/j.eplepsyres.2015.05.009. Epub 2015 Jun 5.Epilepsy Res. 2015.PMID:26220378
- Association between comorbidities and dementia in diabetes mellitus patients: population-based retrospective cohort study.Kuo SC, Lai SW, Hung HC, Muo CH, Hung SC, Liu LL, Chang CW, Hwu YJ, Chen SL, Sung FC.Kuo SC, et al.J Diabetes Complications. 2015 Nov-Dec;29(8):1071-6. doi: 10.1016/j.jdiacomp.2015.06.010. Epub 2015 Jun 29.J Diabetes Complications. 2015.PMID:26233574
- Relationship between diabetes and risk of gastric cancer: A systematic review and meta-analysis of cohort studies.Guo J, Liu C, Pan J, Yang J.Guo J, et al.Diabetes Res Clin Pract. 2022 May;187:109866. doi: 10.1016/j.diabres.2022.109866. Epub 2022 Apr 6.Diabetes Res Clin Pract. 2022.PMID:35398143Review.
- New insights toward molecular and nanotechnological approaches to antidiabetic agents for Alzheimer's disease.Pradhan SP, Sahu PK, Behera A.Pradhan SP, et al.Mol Cell Biochem. 2023 Dec;478(12):2739-2762. doi: 10.1007/s11010-023-04696-1. Epub 2023 Mar 22.Mol Cell Biochem. 2023.PMID:36949264Review.
Cited by
- Linking Diabetes to Alzheimer's Disease: Potential Roles of Glucose Metabolism and Alpha-Glucosidase.Wee AS, Nhu TD, Khaw KY, Tang KS, Yeong KY.Wee AS, et al.Curr Neuropharmacol. 2023;21(10):2036-2048. doi: 10.2174/1570159X21999221111102343.Curr Neuropharmacol. 2023.PMID:36372924Free PMC article.Review.
- Hyperglycemia modulates extracellular amyloid-β concentrations and neuronal activity in vivo.Macauley SL, Stanley M, Caesar EE, Yamada SA, Raichle ME, Perez R, Mahan TE, Sutphen CL, Holtzman DM.Macauley SL, et al.J Clin Invest. 2015 Jun;125(6):2463-7. doi: 10.1172/JCI79742. Epub 2015 May 4.J Clin Invest. 2015.PMID:25938784Free PMC article.
- Peripheral Levels of AGEs and Astrocyte Alterations in the Hippocampus of STZ-Diabetic Rats.Nardin P, Zanotto C, Hansen F, Batassini C, Gasparin MS, Sesterheim P, Gonçalves CA.Nardin P, et al.Neurochem Res. 2016 Aug;41(8):2006-16. doi: 10.1007/s11064-016-1912-2. Epub 2016 Apr 15.Neurochem Res. 2016.PMID:27084774
- Metformin and Dementia Risk: A Systematic Review with Respect to Time Related Biases.Dai J, Ports KD, Corrada MM, Odegaard AO, O'Connell J, Jiang L.Dai J, et al.J Alzheimers Dis Rep. 2022 Aug 3;6(1):443-459. doi: 10.3233/ADR-220002. eCollection 2022.J Alzheimers Dis Rep. 2022.PMID:36186728Free PMC article.
- Hearing Loss is Associated With Risk of Alzheimer's Disease: A Case-Control Study in Older People.Hung SC, Liao KF, Muo CH, Lai SW, Chang CW, Hung HC.Hung SC, et al.J Epidemiol. 2015;25(8):517-21. doi: 10.2188/jea.JE20140147. Epub 2015 May 16.J Epidemiol. 2015.PMID:25986155Free PMC article.
References
- Maiorini AF, Gaunt MJ, Jacobsen TM, McKay AE, Waldman LD, et al. (2002) Potential novel targets for Alzheimer pharmacotherapy: I. secretases. J Clin Pharm Ther 27: 169–183. - PubMed
- Thies W, Bleiler L (2011) 2011 Alzheimer’s disease facts and figures. Alzheimers Dement 7: 208–244. - PubMed
- Wolfson C, Wolfson DB, Asgharian M, M’Lan CE, Ostbye T, et al. (2001) Clinical Progression of Dementia Study Group (2001) A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 344: 1111–1116. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical